The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion

Atheroscler Suppl. 2019 Dec:39:e1-e8. doi: 10.1016/j.atherosclerosissup.2019.08.023. Epub 2019 Aug 17.
No abstract available

Publication types

  • Review

MeSH terms

  • Biological Products / adverse effects
  • Biological Products / pharmacokinetics
  • Biological Products / therapeutic use*
  • Biotransformation
  • Cardiovascular Diseases / chemically induced
  • Cholesterol / blood
  • Clinical Trials as Topic
  • Cytochrome P-450 CYP3A / metabolism
  • Dietary Supplements*
  • Double-Blind Method
  • Expert Testimony
  • Food-Drug Interactions
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / therapy*
  • Lovastatin / adverse effects
  • Lovastatin / chemistry
  • Lovastatin / pharmacokinetics
  • Lovastatin / therapeutic use
  • Medicine, Chinese Traditional
  • Molecular Structure
  • Multicenter Studies as Topic
  • Musculoskeletal Diseases / chemically induced
  • Prodrugs / pharmacokinetics
  • Prodrugs / therapeutic use
  • Randomized Controlled Trials as Topic
  • Self Medication

Substances

  • Biological Products
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Prodrugs
  • red yeast rice
  • Cholesterol
  • Lovastatin
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human